{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "7558798", "DateCompleted": {"Year": "1995", "Month": "10", "Day": "26"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0017-8594", "JournalIssue": {"Volume": "54", "Issue": "7", "PubDate": {"Year": "1995", "Month": "Jul"}}, "Title": "Hawaii medical journal", "ISOAbbreviation": "Hawaii Med J"}, "ArticleTitle": "Acute anticholinergic syndrome following ingestion of Angel's Trumpet tea.", "Pagination": {"StartPage": "669", "EndPage": "670", "MedlinePgn": "669-70"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Investigation, Tripler Army Medical Center, Hawaii, USA."}], "LastName": "Hassell", "ForeName": "L H", "Initials": "LH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "MacMillan", "ForeName": "M W", "Initials": "MW"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Hawaii Med J", "NlmUniqueID": "2984209R", "ISSNLinking": "0017-8594"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinergic Antagonists"}, {"RegistryNumber": "16291-96-6", "NameOfSubstance": "Charcoal"}, {"RegistryNumber": "36B82AMQ7N", "NameOfSubstance": "Naloxone"}, {"RegistryNumber": "DL48G20X8X", "NameOfSubstance": "Scopolamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acute Disease"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Beverages"}, {"QualifierName": [], "DescriptorName": "Charcoal"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Cholinergic Antagonists"}, {"QualifierName": [], "DescriptorName": "Datura stramonium"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Delirium"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Naloxone"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["drug therapy", "etiology"], "DescriptorName": "Psychoses, Substance-Induced"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Scopolamine"}, {"QualifierName": [], "DescriptorName": "Syndrome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1995", "Month": "7", "Day": "1"}, {"Year": "1995", "Month": "7", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "7", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7558798"]}}]}